Reliq Health Technologies (RHT.V) – January 11, 2023 corporate update highlights

Since its January 5, 2023 low of $0.48, RHT.V stock has been on a tear, hitting $0.60 on January 9, 2023 and continuing higher in the subsequent trading sessions.  CEO Lisa Crossley scheduled a corporate update today (January 11, 2023) to review the issuer’s progress and to provide updated guidance.  Here are the highlights of that presentation, from our perspective:

Reliq Health Technologies (RHT.V) – Thoughts on the Q1 FY2023 financials

Yesterday evening (November 29, 2022), RHT.V issued its much-anticipated financial results for Q1 FY2023, followed this morning at 9:00 AM EST by an investor webinar presentation hosted by CEO Lisa Crossley. Investors are encouraged, as always, to review the materials posted on Sedar.

Reliq Health Technologies (RHT.V) – Thoughts on the FY2022 audited annual financials

As is always the case, investors are best served by reviewing original materials released by an issuer. RHT.V’s Audited annual financial statements and Management Discussion and Analysis for the year ended June 30, 2022 are both available at www.sedar.com, along with a news release also filed on November 2, 2022 that provides a summary of important highlights. Investors are also encouraged to view the playback of the shareholder update webinar hosted by CEO Lisa Crossley that took place at noon EDT November 2, 2022, which will be available on the company’s website.

Reliq Health Technologies (RHT.V) – Lytham Partners Fall 2022 Investor Conference highlights

Yesterday (September 28, 2022), Lytham Partners hosted RHT.V CEO Lisa Crossley at their Fall 2022 Investor Conference taking place on September 28 and 29, 2022.  She presented the company to participants and responded to a number of questions.  Here are extracts from comments made by Lisa Crossley that should be of interest to investors:

The appearance of integrity in financial markets

Regulators speak often about the integrity of financial markets, and the rules and actions designed to ensure this. To the ordinary investor, perception in certain circumstances is greatly to the contrary.

Reliq Health Technologies (RHT.V) – Thoughts on the Q3 FY2022 financials

Investors should visit www.sedar.com and read RHT.V’s interim financial statements and Management Discussion and Analysis for the period ended March 31, 2022 (Q3 FY2022), posted May 30, 2022. If they missed the investor webinar hosted by CEO Lisa Crossley this morning (May 31, 2022), playback is available under Corporate Updates on the company’s website: https://www.reliqhealth.com/investors/.